Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Alving

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Hospital Practice (Office Ed.)|February 15, 1993
The hypercoagulable statesB M Alving
Journal of Thrombosis and Thrombolysis|November 17, 2001
Diagnosis and management of patients with the antiphospholipid syndromeB M Alving
Seminars in Thrombosis and Hemostasis|January 1, 1997
Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosisB M Alving, C Krishnamurti
American Journal of Hematology|April 1, 1994
Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosisT Reid, B M Alving
Seminars in Thrombosis and Hemostasis|January 1, 1992
Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivoC Krishnamurti, B M Alving
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1995
Effect of fibrin structure on plasmin-mediated dissolution of plasma clotsM E Carr, B M Alving
American Family Physician|November 1, 1991
Recurrent venous thrombosis and hypercoagulable statesC D Bolan, B M Alving
Thrombosis Research|July 1, 1976
Methods for correcting inhibitory effects of fibrinogen degradation products in fibrinogen determinationsB M Alving, W R Bell
Current Opinion in Hematology|November 5, 1999
Fibrin sealant in preclinical and clinical studiesM R Jackson, B M Alving
Transfusion|July 1, 1990
Pharmacologic agents in the management of bleeding disordersC D Bolan, B M Alving
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Hospital Practice (Office Ed.)|February 15, 1993
The hypercoagulable statesB M Alving
Journal of Thrombosis and Thrombolysis|November 17, 2001
Diagnosis and management of patients with the antiphospholipid syndromeB M Alving
Seminars in Thrombosis and Hemostasis|January 1, 1997
Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosisB M Alving, C Krishnamurti
American Journal of Hematology|April 1, 1994
Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosisT Reid, B M Alving
Seminars in Thrombosis and Hemostasis|January 1, 1992
Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivoC Krishnamurti, B M Alving
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 1995
Effect of fibrin structure on plasmin-mediated dissolution of plasma clotsM E Carr, B M Alving
American Family Physician|November 1, 1991
Recurrent venous thrombosis and hypercoagulable statesC D Bolan, B M Alving
Thrombosis Research|July 1, 1976
Methods for correcting inhibitory effects of fibrinogen degradation products in fibrinogen determinationsB M Alving, W R Bell
Current Opinion in Hematology|November 5, 1999
Fibrin sealant in preclinical and clinical studiesM R Jackson, B M Alving
Transfusion|July 1, 1990
Pharmacologic agents in the management of bleeding disordersC D Bolan, B M Alving
Pageof 9